Response to baricitinib therapy in patients with rheumatoid arthritis with inadequate response to csDMARDs as a function of baseline characteristics

OBJECTIVE: We analysed the effects of baseline characteristics on the safety and efficacy of baricitinib in patients with rheumatoid arthritis (RA) with inadequate response to conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) from two phase III trials. METHODS: In RA-BEAM (NCT0...

Descripción completa

Detalles Bibliográficos
Autores principales: Kremer, Joel M, Schiff, Michael, Muram, David, Zhong, Jinglin, Alam, Jahangir, Genovese, Mark C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822634/
https://www.ncbi.nlm.nih.gov/pubmed/29479473
http://dx.doi.org/10.1136/rmdopen-2017-000581

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5822634/
https://www.ncbi.nlm.nih.gov/pubmed/29479473
http://dx.doi.org/10.1136/rmdopen-2017-000581

Ejemplares similares